Jonathan Emms became the President of the ABPI on 11 April 2014. Jonathan has been UK Managing Director of Pfizer Ltd since January 2012 and is also the UK Head of Pfizer’s Global Innovative Pharmaceuticals Business.
Prior to 2012, Jonathan spent seven years in Paris where he worked as the European Marketing Head for Pfizer, establishing the European Speciality Asset Teams. Before this Jonathan held a number of positions of increasing responsibility across the UK sales and marketing organisation. Before joining Pfizer, Jonathan spent 10 years at GlaxoSmithKline.
Jonathan has played an active role in industry affairs since his return to the UK. He has served on the ABPI’s Board of Management since 2012 and was a member of the ABPI’s negotiating team for the 2014 PPRS pricing agreement. Jonathan is also a member of the Policy Board of the Office of Health Economics (OHE) and a member of the American Pharmaceutical Group (APG).